Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.

Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, Shinefield HR.

Pediatr Infect Dis J. 2006 Apr;25(4):293-300.

PMID:
16567979
2.

Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization.

Klein JO.

Pediatr Infect Dis J. 2002 Jun;21(6):584-8; discussion 613-4. Review.

PMID:
12182394
3.

The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.

Toltzis P, Jacobs MR.

Infect Dis Clin North Am. 2005 Sep;19(3):629-45. Review.

PMID:
16102653
4.

Pneumococcal vaccines: do they prevent infection and how?

Posfay-Barbe KM, Wald ER.

Curr Opin Infect Dis. 2004 Jun;17(3):177-84. Review.

PMID:
15166818
5.

Bacteremia in feverish children presenting to the emergency department: a retrospective study and literature review.

Bressan S, Berlese P, Mion T, Masiero S, Cavallaro A, Da Dalt L.

Acta Paediatr. 2012 Mar;101(3):271-7. doi: 10.1111/j.1651-2227.2011.02478.x. Epub 2011 Oct 15. Review.

PMID:
21950707
6.

[Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].

de Arístegui Fernández J, Corretger Rauet JM, García Martín F, Hernández-Sampelayo T, Moraga Llop FA, Rodrigo Gonzalo De Liria C, Ruiz Contreras J; Comité Asesor deVacunas de la Asociación Española de Pediatría.

An Esp Pediatr. 2002 Jan;56(1):79-90. Review. Spanish.

PMID:
11792258
7.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
8.

The potential of pneumococcal conjugate vaccines for children.

Whitney CG, Pickering LK.

Pediatr Infect Dis J. 2002 Oct;21(10):961-70. Review.

PMID:
12394822
9.

Occult pneumococcal bacteremia: a review.

Joffe MD, Alpern ER.

Pediatr Emerg Care. 2010 Jun;26(6):448-54; quiz 455-7. doi: 10.1097/PEC.0b013e3181e15e36. Review.

PMID:
20531134
10.

[New pneumococcal vaccine].

Gaudelus J.

Bull Acad Natl Med. 2003;187(8):1477-86; discussion 1486-8. Review. French.

PMID:
15146579
12.

Heptavalent pneumococcal conjugate vaccine: current and future impact.

Hsu KK, Pelton SI.

Expert Rev Vaccines. 2003 Oct;2(5):619-31. Review.

PMID:
14711324
13.

Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.

Bricks LF, Berezin E.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S67-74. Epub 2006 May 19. Review.

14.

[Heptavalent-pneumococcal conjugate vaccine (Prevenar). Differences in effectiveness between populations].

Guevara M, Barricarte A, Pérez B, Arriazu M, García Cenoz M, Castilla J.

An Sist Sanit Navar. 2008 May-Aug;31(2):171-92. Review. Spanish.

15.

[Pneumococcal infection is a vaccine-preventable disease now].

Tatochenko VK.

Zh Mikrobiol Epidemiol Immunobiol. 2010 May-Jun;(3):102-8. Review. Russian.

PMID:
20734728
16.

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):189-209. doi: 10.1055/s-0029-1202938. Epub 2009 Mar 18. Review.

PMID:
19296419
17.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
18.

[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].

de Greeff SC, Sanders EA, de Melker HE, van der Ende A, Vermeer PE, Schouls LM.

Ned Tijdschr Geneeskd. 2007 Jun 30;151(26):1454-7. Review. Dutch.

PMID:
17633974
19.

Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.

Dagan R.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Review.

20.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452

Supplemental Content

Support Center